D L Carlson Investment Group Inc. Has $1.09 Million Holdings in LivaNova PLC (NASDAQ:LIVN)

D L Carlson Investment Group Inc. decreased its holdings in shares of LivaNova PLC (NASDAQ:LIVN) by 2.3% in the 4th quarter, Holdings Channel reports. The fund owned 23,483 shares of the company’s stock after selling 541 shares during the period. D L Carlson Investment Group Inc.’s holdings in LivaNova were worth $1,087,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Central Pacific Bank Trust Division grew its stake in shares of LivaNova by 21.2% during the fourth quarter. Central Pacific Bank Trust Division now owns 4,117 shares of the company’s stock worth $191,000 after buying an additional 720 shares during the last quarter. Vestcor Inc bought a new stake in LivaNova during the 4th quarter worth $204,000. Captrust Financial Advisors acquired a new position in LivaNova in the 3rd quarter worth about $217,000. Inceptionr LLC bought a new position in LivaNova in the fourth quarter valued at about $217,000. Finally, Sanctuary Advisors LLC acquired a new stake in shares of LivaNova during the third quarter valued at about $219,000. Institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently commented on LIVN. Stifel Nicolaus cut their target price on shares of LivaNova from $72.00 to $60.00 and set a “buy” rating on the stock in a research report on Wednesday, February 26th. Needham & Company LLC reaffirmed a “buy” rating and set a $64.00 target price on shares of LivaNova in a research note on Monday, March 17th. Barclays dropped their price objective on shares of LivaNova from $58.00 to $56.00 and set an “equal weight” rating on the stock in a report on Friday, March 7th. Mizuho lowered their target price on LivaNova from $70.00 to $60.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 26th. Finally, Wolfe Research lowered shares of LivaNova from an “outperform” rating to a “peer perform” rating in a report on Wednesday, February 26th. Two analysts have rated the stock with a hold rating, five have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $61.17.

LivaNova Stock Down 1.2 %

LIVN opened at $39.13 on Monday. The company’s 50-day moving average price is $44.51 and its two-hundred day moving average price is $48.48. The company has a quick ratio of 2.87, a current ratio of 3.37 and a debt-to-equity ratio of 0.46. LivaNova PLC has a twelve month low of $36.85 and a twelve month high of $64.48. The stock has a market cap of $2.13 billion, a price-to-earnings ratio of 93.17 and a beta of 1.10.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.